GDC-0326 Enhances the Effects of 5-Fu in Colorectal Cancer Cells by Inducing Necroptotic Death

References

• Wang JH, Lu TJ, Kung ML, et al. The long noncoding RNA LOC441461 (STX17-AS1) modulates colorectal cancer cell growth and motility. Cancers. 2020;12(11):3171. doi:10.3390/cancers12113171
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Dittrich L, Biebl M, Schmuck R, et al. Initial experience with the safe implementation of Transanal Total Mesorectal Excision (TaTME) as a standardized procedure for low rectal cancer. J Clin Med. 2020;10(1):72. doi:10.3390/jcm10010072
   PubMed Web of Science ®Google Scholar
• Fletcher JI, Haber M, Henderson MJ, Norris MD. ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer. 2010;10(2):147–156. doi:10.1038/nrc2789
   PubMed Web of Science ®Google Scholar
• Wosikowski K, Schuurhuis D, Kops GJ, Saceda M, Bates SE. Altered gene expression in drug-resistant human breast cancer cells. Clin Cancer Res. 1997;3(12 Pt 1):2405–2414.
   PubMed Web of Science ®Google Scholar
• Zhang YH, Luo DD, Wan SB, Qu XJ. S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancer. Pharmacol Res. 2020;155:104717. doi:10.1016/j.phrs.2020.104717
   PubMed Web of Science ®Google Scholar
• Wang W, Guo W, Li L, et al. Andrographolide reversed 5-FU resistance in human colorectal cancer by elevating BAX expression. Biochem Pharmacol. 2016;121:8–17. doi:10.1016/j.bcp.2016.09.024
   PubMed Web of Science ®Google Scholar
• Țigu AB, Toma VA, Moț AC, et al. The synergistic antitumor effect of 5-fluorouracil combined with allicin against lung and colorectal carcinoma cells. Molecules. 2020;25(8):1947. doi:10.3390/molecules25081947
   PubMed Web of Science ®Google Scholar
• Feng Y, Gao Y, Wang D, et al. Autophagy inhibitor (LY294002) and 5-fluorouracil (5-FU) combination-based nanoliposome for enhanced efficacy against esophageal squamous cell carcinoma. Nanoscale Res Lett. 2018;13(1):325. doi:10.1186/s11671-018-2716-x
   PubMed Web of Science ®Google Scholar
• Liu F, Ai F-Y, Zhang D-C, et al. LncRNA NEAT1 knockdown attenuates autophagy to elevate 5-FU sensitivity in colorectal cancer via targeting miR-34a. Cancer Med. 2020;9(3):1079–1091. doi:10.1002/cam4.2746
   PubMed Web of Science ®Google Scholar
• Gao J, Qiu X, Xi G, et al. Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in nonsmall cell lung cancer. Oncol Rep. 2018;40(4):1971–1984. doi:10.3892/or.2018.6634
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang Y, Xia S, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020;579(7799):415–420. doi:10.1038/s41586-020-2071-9
   PubMed Web of Science ®Google Scholar
• Zhu Y, Hu H, Yuan Z, et al. LncRNA NEAT1 remodels chromatin to promote the 5-Fu resistance by maintaining colorectal cancer stemness. Cell Death Dis. 2020;11(11):962. doi:10.1038/s41419-020-03164-8
   PubMed Web of Science ®Google Scholar
• Kroemer G, Galluzzi L, Vandenabeele P, et al. Classification of cell death: recommendations of the nomenclature committee on cell death 2009. Cell Death Differ. 2009;16(1):3–11. doi:10.1038/cdd.2008.150
   PubMed Web of Science ®Google Scholar
• Lu X, Fu H, Chen R, et al. Phosphoinositide specific phospholipase Cγ1 inhibition-driven autophagy caused cell death in human lung adenocarcinoma A549 cells in vivo and in vitro. Int J Biol Sci. 2020;16(8):1427–1440. doi:10.7150/ijbs.42962
   PubMed Web of Science ®Google Scholar
• Christofferson DE, Yuan J. Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol. 2010;22(2):263–268. doi:10.1016/j.ceb.2009.12.003
   PubMed Web of Science ®Google Scholar
• Zheng W, Zhou CY, Zhu XQ, et al. Oridonin enhances the cytotoxicity of 5-FU in renal carcinoma cells by inducting necroptotic death. Biomed Pharmacother. 2018;106:175–182. doi:10.1016/j.biopha.2018.06.111
   PubMed Web of Science ®Google Scholar
• Linkermann A, Green DR. Necroptosis. N Engl J Med. 2014;370(5):455–465. doi:10.1056/NEJMra1310050
   PubMed Web of Science ®Google Scholar
• Chen C, Xiao W, Huang L, et al. Shikonin induces apoptosis and necroptosis in pancreatic cancer via regulating the expression of RIP1/RIP3 and synergizes the activity of gemcitabine. Am J Transl Res. 2017;9(12):5507–5517.
   PubMed Web of Science ®Google Scholar
• Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer. 2002;2(7):489–501. doi:10.1038/nrc839
   PubMed Web of Science ®Google Scholar
• Fritsch C, Huang A, Chatenay-Rivauday C, et al. Characterization of the novel and specific PI3Kalpha inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials. Mol Cancer Ther. 2014;13(5):1117–1129. doi:10.1158/1535-7163.MCT-13-0865
   PubMed Web of Science ®Google Scholar
• Furet P, Guagnano V, Fairhurst RA, et al. Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation. Bioorg Med Chem Lett. 2013;23(13):3741–3748. doi:10.1016/j.bmcl.2013.05.007
   PubMed Web of Science ®Google Scholar
• McNamara CR, Ahuja R, Osafo-Addo AD, et al. Akt regulates TNFalpha synthesis downstream of RIP1 kinase activation during necroptosis. PLoS One. 2013;8(3):e56576. doi:10.1371/journal.pone.0056576
   PubMed Web of Science ®Google Scholar
• Soler A, Figueiredo AM, Castel P, et al. Therapeutic benefit of selective inhibition of p110alpha PI3-kinase in pancreatic neuroendocrine tumors. Clin Cancer Res. 2016;22(23):5805–5817. doi:10.1158/1078-0432.CCR-15-3051
   PubMed Web of Science ®Google Scholar
• Heffron TP, Heald RA, Ndubaku C, et al. The rational design of selective benzoxazepin inhibitors of the alpha-isoform of phosphoinositide 3-kinase culminating in the identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326). J Med Chem. 2016;59(3):985–1002. doi:10.1021/acs.jmedchem.5b01483
   PubMed Web of Science ®Google Scholar
• Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70(2):440–446. doi:10.1158/0008-5472.Can-09-1947
   PubMed Web of Science ®Google Scholar
• Ashton JC. Drug combination studies and their synergy quantification using the Chou-Talalay method–letter. Cancer Res. 2015;75(11):2400. doi:10.1158/0008-5472.CAN-14-3763
   PubMed Web of Science ®Google Scholar
• Sinzger M, Vanhoefer J, Loos C, Hasenauer J. Comparison of null models for combination drug therapy reveals hand model as biochemically most plausible. Sci Rep. 2019;9(1):3002. doi:10.1038/s41598-019-38907-x
   PubMedGoogle Scholar
• Scheiblecker L, Kollmann K, Sexl V. CDK4/6 and MAPK-crosstalk as opportunity for cancer treatment. Pharmaceuticals. 2020;13(12):418. doi:10.3390/ph13120418
   Web of Science ®Google Scholar
• Ji M, Li Z, Lin Z, Chen L. Antitumor activity of the novel HDAC inhibitor CUDC-101 combined with gemcitabine in pancreatic cancer. Am J Cancer Res. 2018;8(12):2402–2418.
   PubMed Web of Science ®Google Scholar
• Li YM, Liu ZY, Wang JC, et al. Receptor-interacting protein kinase 3 deficiency recruits myeloid-derived suppressor cells to hepatocellular carcinoma through the chemokine (C-X-C motif) ligand 1-chemokine (C-X-C motif) receptor 2 axis. Hepatology. 2019;70(5):1564–1581. doi:10.1002/hep.30676
   PubMed Web of Science ®Google Scholar
• Zhang J, Roberts TM, Shivdasani RA. Targeting PI3K signaling as a therapeutic approach for colorectal cancer. Gastroenterology. 2011;141(1):50–61. doi:10.1053/j.gastro.2011.05.010
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang H, Ding K, Xu J. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. Toxicol Lett. 2015;236(1):43–59. doi:10.1016/j.toxlet.2015.04.015
   PubMed Web of Science ®Google Scholar
• Mishra SK, Stephenson DJ, Chalfant CE, Brown RE. Upregulation of human glycolipid transfer protein (GLTP) induces necroptosis in colon carcinoma cells. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(2):158–167. doi:10.1016/j.bbalip.2018.11.002
   PubMed Web of Science ®Google Scholar
• Xin Y, Huang Q, Tang JQ, et al. Nanoscale drug delivery for targeted chemotherapy. Cancer Lett. 2016;379(1):24–31. doi:10.1016/j.canlet.2016.05.023
   PubMed Web of Science ®Google Scholar
• Ding Z, Wang L, Xing Y, et al. Enhanced oral bioavailability of celecoxib nanocrystalline solid dispersion based on wet media milling technique: formulation, optimization and in vitro/in vivo evaluation. Pharmaceutics. 2019;11(7):328. doi:10.3390/pharmaceutics11070328
   PubMed Web of Science ®Google Scholar